Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC

Clinical trial NCT02531425 · COMPLETED

Trial details

NCT number: NCT02531425
Sponsor: OncoSec Medical Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

ER-Negative PR-Negative HER2-Negative Breast Cancer

Start date: 2015-09-01
Primary completion: 2018-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.